Co-administration of cholesterol-lowering probiotics and anthraquinone from Cassia obtusifolia L. Ameliorate non-alcoholic fatty liver

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Mei, Lu ^a,b   Tang, Youcai ^a   Li, Ming ^b   Yang, Pingchang ^d   Liu, Zhiqiang ^c   Yuan, Jieli ^b   Zheng, Pengyuan ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c ENT Hospital   (China)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAQUINONE; BETA ACTIN; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; FARNESOID X RECEPTOR; FATTY ACID; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; OCCLUDIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROBIOTIC AGENT; PROTEIN ZO1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; 9,10-ANTHRAQUINONE; ANTHRAQUINONE DERIVATIVE; BIOLOGICAL MARKER; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMMUNITY STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; FATTY ACID BLOOD LEVEL; GENE EXPRESSION; GLUCOSE TOLERANCE; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LIPID DIET; LIPID METABOLISM; LIPOGENESIS; LIPOPROTEIN BLOOD LEVEL; MALE; MICROBIAL DIVERSITY; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; RAT MODEL; SENNA OBTUSIFOLIA; SPRAGUE DAWLEY RAT; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; ANIMAL; CASSIA; CHEMISTRY; COMBINATION DRUG THERAPY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTHRAQUINONES; BIOMARKERS; BLOTTING, WESTERN; CASSIA; CHOLESTEROL; DRUG THERAPY, COMBINATION; GENE EXPRESSION PROFILING; LIPID METABOLISM; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; PROBIOTICS; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84945915021     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138078     Document Type: Article

References (48)

1. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011; 140(1):124-31. Epub 2010/09/23. doi: 10.1053/j.gastro.2010.09.038 PMID: 20858492.
2. Hashimoto E, Tokushige K. Prevalence, gender, ethnic variations, and prognosis of NASH. J Gastroenterol. 2011; 46 Suppl 1:63-9. Epub 2010/09/17. doi: 10.1007/s00535-010-0311-8 PMID: 20844903.
3. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012; 482(7384):179-85. Epub 2012/02/03. doi: 10.1038/nature10809 PMID: 22297845; PubMed Central PMCID: PMCPMC3276682.
4. Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010; 52(5):1836-46. Epub 2010/11/03. doi: 10.1002/hep.24001 PMID: 21038418.
5. Fouts DE, Torralba M, Nelson KE, Brenner DA, Schnabl B. Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease. Journal of hepatology. 2012; 56(6):1283-92. Epub 2012/02/14. doi: 10.1016/j.jhep.2012.01.019 PMID: 22326468; PubMed Central PMCID: PMCPmc3357486.
6. Le Roy T, Llopis M, Lepage P, Bruneau A, Rabot S, Bevilacqua C, et al. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut. 2013; 62(12):1787-94. Epub 2012/12/01. doi: 10.1136/gutjnl-2012-303816 PMID: 23197411.
7. Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. 2009; 49(6):1877-87. Epub 2009/03/18. doi: 10.1002/hep.22848 PMID: 19291785.
8. Liong MT. Probiotics: a critical review of their potential role as antihypertensives, immune modulators, hypocholesterolemics, and perimenopausal treatments. Nutrition reviews. 2007; 65(7):316-28. Epub 2007/08/19. PMID: 17695372.
9. Andrade ME, Araujo RS, de Barros PA, Soares AD, Abrantes FA, Generoso SV, et al. The role of immunomodulators on intestinal barrier homeostasis in experimental models. Clinical nutrition (Edinburgh, Scotland). 2015. Epub 2015/02/11. doi: 10.1016/j.clnu.2015.01.012 PMID: 25660317.
10. Astrup A. Yogurt and dairy product consumption to prevent cardiometabolic diseases: epidemiologic and experimental studies. Am J Clin Nutr. 2014; 99(5 Suppl):1235s-42s. Epub 2014/04/04. doi: 10.3945/ajcn.113.073015 PMID: 24695891.
11. El Khoury D, Goff H, Anderson G. The role of alginates in regulation of food intake and glycemia: a gastroenterological perspective. Critical Reviews in Food Science and Nutrition. 2013;(just-accepted).
12. Jang DS, Lee GY, Kim YS, Lee YM, Kim CS, Yoo JL, et al. Anthraquinones from the seeds of Cassia tora with inhibitory activity on protein glycation and aldose reductase. Biological & pharmaceutical bulletin. 2007; 30(11):2207-10. Epub 2007/11/06. PMID: 17978503.
13. Ju MS, Kim HG, Choi JG, Ryu JH, Hur J, Kim YJ, et al. Cassiae semen, a seed of Cassia obtusifolia, has neuroprotective effects in Parkinson's disease models. Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association. 2010; 48(8-9):2037-44. Epub 2010/05/12. doi: 10.1016/j.fct.2010.05.002 PMID: 20457209.
14. Patil UK, Saraf S, Dixit VK. Hypolipidemic activity of seeds of Cassia tora Linn. Journal of ethnopharmacology. 2004; 90(2-3):249-52. Epub 2004/03/12. doi: 10.1016/j.jep.2003.10.007 PMID: 15013188.
15. Dhanasekaran M, Ignacimuthu S, Agastian P. Potential hepatoprotective activity of ononitol monohydrate isolated from Cassia tora L. on carbon tetrachloride induced hepatotoxicity in wistar rats. Phytomedicine: international journal of phytotherapy and phytopharmacology. 2009; 16(9):891-5. Epub 2009/04/07. doi: 10.1016/j.phymed.2009.02.006 PMID: 19345078.
16. Tzeng TF, Lu HJ, Liou SS, Chang CJ, Liu IM. Cassia tora (Leguminosae) seed extract alleviates highfat diet-induced nonalcoholic fatty liver. Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association. 2013; 51:194-201. Epub 2012/10/03. doi: 10.1016/j.fct.2012.09.024 PMID: 23026700.
17. Luo X, Xu X, Huang C, Wu X, Liu J, Lan B, et al. [Experiment study of total anthraquinone in cassiae semen on lipid peroxidation and PPAR-gamma expression in liver tissues of rats with alcoholic fatty liver]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. 2011; 36(12):1654-9. Epub 2011/10/20. PMID: 22007555.
18. Feng HW, Pi CM, Wang RB, Chen LC. Use of ferric ammonium sulfate in serum cholesterol determination. Clinical chemistry. 1973; 19(1):121-2. Epub 1973/01/01. PMID: 4683356.
19. Li M, Yang D, Mei L, Yuan L, Xie A, Yuan J. Screening and characterization of purine nucleoside degrading lactic acid bacteria isolated from Chinese sauerkraut and evaluation of the serum uric acid lowering effect in hyperuricemic rats. PLoS One. 2014; 9(9):e105577. Epub 2014/09/04. doi: 10.1371/journal.pone.0105577 PMID: 25184445; PubMed Central PMCID: PMCPmc4153548.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7):412-9. Epub 1985/07/01. PMID: 3899825.
21. DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, et al. Greengenes, a chimerachecked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006; 72(7):5069-72. Epub 2006/07/06. doi: 10.1128/aem.03006-05 PMID: 16820507 PubMed Central PMCID: PMCPmc1489311.
22. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics (Oxford, England). 2010; 26(19):2460-1. Epub 2010/08/17. doi: 10.1093/bioinformatics/btq461 PMID: 20709691.
23. Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007; 73(16):5261-7. Epub 2007/06/26. doi: 10.1128/aem.00062-07 PMID: 17586664; PubMed Central PMCID: PMCPmc1950982.
24. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990; 215(3):403-10. Epub 1990/10/05. doi: 10.1016/s0022-2836(05)80360-2 PMID: 2231712.
25. Eckard C, Cole R, Lockwood J, Torres DM, Williams CD, Shaw JC, et al. Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial. Therap Adv Gastroenterol. 2013; 6(4):249-59. Epub 2013/07/03. doi: 10.1177/1756283x13484078 PMID: 23814606; PubMed Central PMCID: PMCPMC3667474.
26. Finelli C, Tarantino G. Have guidelines addressing physical activity been established in nonalcoholic fatty liver disease? World journal of gastroenterology: WJG. 2012; 18(46):6790-800. Epub 2012/12/15. doi: 10.3748/wjg.v18.i46.6790 PMID: 23239917; PubMed Central PMCID: PMCPMC3520168.
27. Moore JB. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome. The Proceedings of the Nutrition Society. 2010; 69(2):211-20. Epub 2010/02/18. doi: 10.1017/s0029665110000030 PMID: 20158939.
28. Xu ZJ, Fan JG, Ding XD, Qiao L, Wang GL. Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats. Digestive diseases and sciences. 2010; 55(4):931-40. Epub 2009/05/22. doi: 10.1007/s10620-009-0815-3 PMID: 19459046; PubMed Central PMCID: PMCPmc2946554.
29. Abbott RD, Wilson PW, Kannel WB, Castelli WP. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study. Arteriosclerosis (Dallas, Tex). 1988; 8 (3):207-11. Epub 1988/05/01. PMID: 3370018.
30. Shanmugasundaram KR, Visvanathan A, Dhandapani K, Srinivasan N, Rasappan P, Gilbert R, et al. Effect of high-fat diet on cholesterol distribution in plasma lipoproteins, cholesterol esterifying activity in leucocytes, and erythrocyte membrane components studied: importance of body weight. Am J Clin Nutr. 1986; 44(6):805-15. Epub 1986/12/01. PMID: 3788831.
31. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science (New York, NY). 1986; 232(4746):34-47. Epub 1986/04/04. PMID: 3513311.
32. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature. 1990; 343(6257):425-30. Epub 1990/02/01. doi: 10.1038/343425a0 PMID: 1967820.
33. Li T, Owsley E, Matozel M, Hsu P, Novak CM, Chiang JY. Transgenic expression of cholesterol 7alphahydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice. Hepatology. 2010; 52(2):678-90. Epub 2010/07/14. doi: 10.1002/hep.23721 PMID: 20623580; PubMed Central PMCID: PMCPmc3700412.
34. Song KH, Li T, Owsley E, Strom S, Chiang JY. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression. Hepatology. 2009; 49(1):297-305. Epub 2008/12/17. doi: 10.1002/hep.22627 PMID: 19085950; PubMed Central PMCID: PMCPmc2614454.
35. Han KH, Iijuka M, Shimada K, Sekikawa M, Kuramochi K, Ohba K, et al. Adzuki resistant starch lowered serum cholesterol and hepatic 3-hydroxy-3-methylglutaryl-CoA mRNA levels and increased hepatic LDL-receptor and cholesterol 7alpha-hydroxylase mRNA levels in rats fed a cholesterol diet. The British journal of nutrition. 2005; 94(6):902-8. Epub 2005/12/15. PMID: 16351766.
36. Kim I, Ahn SH, Inagaki T, Choi M, Ito S, Guo GL, et al. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. Journal of lipid research. 2007; 48(12):2664-72. Epub 2007/08/28. doi: 10.1194/jlr.M700330-JLR200 PMID: 17720959.
37. Gurnell M. Peroxisome proliferator-activated receptor gamma and the regulation of adipocyte function: lessons from human genetic studies. Best practice & research Clinical endocrinology & metabolism. 2005; 19(4):501-23. Epub 2005/11/29. doi: 10.1016/j.beem.2005.10.001 PMID: 16311214.
38. Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H, et al. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell. 2003; 113(2):159-70. Epub 2003/04/23. PMID: 12705865.
39. Stoeckman AK, Towle HC. The role of SREBP-1c in nutritional regulation of lipogenic enzyme gene expression. The Journal of biological chemistry. 2002; 277(30):27029-35. Epub 2002/05/23. doi: 10.1074/jbc.M202638200 PMID: 12016216.
40. Cordero A, Laclaustra M, Leon M, Casasnovas JA, Grima A, Luengo E, et al. Comparison of serum lipid values in subjects with and without the metabolic syndrome. Am J Cardiol. 2008; 102(4):424-8. Epub 2008/08/06. doi: 10.1016/j.amjcard.2008.03.079 PMID: 18678299.
41. Watanabe M, Houten SM, Wang L, Moschetta A, Mangelsdorf DJ, Heyman RA, et al. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. The Journal of clinical investigation. 2004; 113(10):1408-18. Epub 2004/05/18. doi: 10.1172/jci21025 PMID: 15146238; PubMed Central PMCID: PMCPmc406532.
42. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 2010; 107(33):14691-6. Epub 2010/08/04. doi: 10.1073/pnas.1005963107 PMID: 20679230; PubMed Central PMCID: PMCPmc2930426.
43. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006; 444(7122):1022-3. Epub 2006/12/22. doi: 10.1038/4441022a PMID: 17183309.
44. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med. 2000; 343 (20):1467-76. Epub 2000/11/18. doi: 10.1056/nejm200011163432007 PMID: 11078773.
45. Tarantino G, Conca P, Pasanisi F, Ariello M, Mastrolia M, Arena A, et al. Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur J Gastroenterol Hepatol. 2009; 21(5):504-11. Epub 2009/03/26. doi: 10.1097/MEG.0b013e3283229b40 PMID: 19318968.
46. Lesmana CR, Hasan I, Budihusodo U, Gani RA, Krisnuhoni E, Akbar N, et al. Diagnostic value of a group of biochemical markers of liver fibrosis in patients with non-alcoholic steatohepatitis. J Dig Dis. 2009; 10(3):201-6. Epub 2009/08/08. doi: 10.1111/j.1751-2980.2009.00386.x PMID: 19659788.
47. Ritze Y, Bardos G, Claus A, Ehrmann V, Bergheim I, Schwiertz A, et al. Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice. PLoS One. 2014; 9(1):e80169. Epub 2014/01/30. doi: 10.1371/journal.pone.0080169 PMID: 24475018; PubMed Central PMCID: PMCPmc3903470.
48. Wagnerberger S, Spruss A, Kanuri G, Stahl C, Schroder M, Vetter W, et al. Lactobacillus casei Shirota protects from fructose-induced liver steatosis: a mouse model. The Journal of nutritional biochemistry. 2013; 24(3):531-8. Epub 2012/07/04. doi: 10.1016/j.jnutbio.2012.01.014 PMID: 22749137.